Perspective Therapeutics, Inc. (CATX) Tops Q1 EPS by 6c

Perspective Therapeutics, Inc. (NYSE: CATX) reported Q1 EPS of ($0.25), $0.06 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Winnebago Industries refinances credit facility, extends maturity to 2031
• FTC files amicus brief challenging Amgen's Enbrel patent acquisition